Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it
WASHINGTON (AP) — U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease. The Food and Drug Administration decision clears the way for Medicare and other insurers to begin paying…